Unlike similar vaccines being developed elsewhere, Russia has moved ahead with approving a version before completing so-called phase 3 clinical trials.

Unlike similar vaccines being developed elsewhere, Russia has moved ahead with approving a version before completing so-called phase 3 clinical trials.
